Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.812
Peer-review started: September 28, 2020
First decision: November 3, 2020
Revised: November 23, 2020
Accepted: December 10, 2020
Article in press: December 10, 2020
Published online: February 6, 2021
Processing time: 119 Days and 1.7 Hours
The cardiovascular benefit of statins depends on their compliance, and the cardiovascular events may be related to discontinued application of statins. However, it is unclear whether different administration methods have an effect on coronary artery plaques.
Taking statins can cause plaque regression, but the effects of discontinued and intermittent statins applications on coronary artery plaques are unclear.
To analyse the effects of different statin application methods on plaques in patients with coronary atherosclerosis.
Patients were divided into three groups: Discontinued application of statins, intermittent application of statins, and sustained application of statins groups. The effects of the different statins application methods on coronary atherosclerotic plaques were assessed.
The results found the volume change and rate of change in the most severe plaques significantly decreased and correlated positively with low density lipoprotein cholesterol (LDL-C) only in the sustained statins application group, but there were no changes in the intermittent and discontinued statins application groups.
Only with continuous statin administration can a reduction in LDL-C levels result in plaque volume shrinkage, but not discontinued or intermittent administration of statins.
It is important to strengthen the management of patients and the promotion of patients' health education, disease knowledge, and medication knowledge to improve patients' medication compliance and truly improve clinical prognosis.
